B-1 cells are a self-reactive sub-class of B cells that continuously produce antibodies that can react against the body’s own substances. However, they are beneficial rather than harmful, as there is sometimes a need for weak self-reactivity to deal with dying or dead cells. B1-cells therefore help to clean up, so that inflammation does not arise in the body.
Previously, it has not been understood why the immune system could allow these particular self-reactive cells to exist. There are very strict quality controls in the immune system, which eliminate other self-reactive cells to prevent the development of autoimmune diseases.
“We have discovered a mechanism in the form of a protein, which during a strictly regulated period in the neonatal immune development of mice, allows the production of B1-cells. These B1-cells develop during the foetus stage and until two weeks after the birth. After that, the protein is gone and the window for B1 cell development closes”, says Joan Yuan, research team leader at the Department of Laboratory Medicine.
The protein that makes the process possible is Lin28b. If the protein is lacking, B1-cells development is impaired, but if it is overexpressed, B1-cells also mature in adult mice.
“The adult immune system is thus composed of a mix of newly produced cells and cells that have developed early in life and remain throughout life. We believe that immune cells have specific roles depending on when they developed and protect the body in different ways. The long-lived immune cells carry with them memories of previous experiences, so all the environmental encounters at the very start of life are signals that help to form the lifelong immune system.”
The protein identified by the research team therefore helps to shape the formation of the immune system by allowing for certain self-reactive cells. The long-lived pool of B1-cells have a special importance for programming the immune system for life and may contribute to regulating autoimmune diseases and cancer.
“Even though the experiments were on mice, interesting parallels with humans have already been noted, as cells with properties similar to the B1-cells have been found in umbilical cord blood. The next step is to understand how we can link our discoveries to B-cell cancer and autoimmune diseases”, concludes Joan Yuan.
Contact
Joan Yuan, associate professor of immunology and research team leader at Developmental Immunology and the strategic research area Stem Therapy, Lund University, +46 725 868802, joan [dot] yuan [at] med [dot] lu [dot] se (joan[dot]yuan[at]med[dot]lu[dot]se)
Åsa Hansdotter